Global Expansion Opportunities Curia is actively expanding its manufacturing footprint with recent facility expansions in Glasgow, United Kingdom, and Albuquerque, New Mexico, indicating a commitment to increasing global production capacity. Sales teams can leverage these expansion efforts to offer customized manufacturing solutions, regulatory support, and integrated service packages aligned with their growth.

Investment in Advanced Technologies The company has invested $4 million in upgrading API aseptic suites in Valladolid, Spain, reflecting a focus on state-of-the-art manufacturing infrastructure. This opens doors for sales prospects involving cutting-edge bioprocessing equipment, technology integration, and advanced analytical services.

Strategic Facility Closures Curia's recent shutdown of operations in Burlington, Canada, and the planned closure of a manufacturing site in Massachusetts highlight opportunities to offer tailored manufacturing, process optimization, and alternative site solutions for clients seeking reliable partners during their own operational transitions.

Industry Leadership and Recognition Being named Massachusetts Manufacturer of the Year and recognized for manufacturing excellence positions Curia as a credible partner for businesses seeking high-quality production and development services, presenting opportunities for collaborations in complex biologics and small molecule manufacturing projects.

Growing Market Presence With revenue estimates between $1 billion and $10 billion and an extensive network of over 3,500 employees across globally distributed sites, Curia demonstrates a strong market position. This provides sales opportunities for integrated solutions across discovery, development, and commercialization phases, especially in biologics and small molecules.